Attached files
file | filename |
---|---|
EX-5.1 - EX-5.1 - Oaktree Specialty Lending Corp | d893275dex51.htm |
EX-4.1 - EX-4.1 - Oaktree Specialty Lending Corp | d893275dex41.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 25, 2020
Oaktree Specialty Lending Corporation
(Exact name of Registrant as specified in its charter)
Delaware | 814-00755 | 26-1219283 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
333 South Grand Avenue, 28th Floor Los Angeles, CA |
90071 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (213) 830-6300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Common stock, par value $0.01 per share | OCSL | The Nasdaq Stock Market LLC | ||
5.875% Unsecured Notes due 2024 | OSLE | The New York Stock Exchange | ||
6.125% Unsecured Notes due 2028 | OCSLL | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. | Entry into a Material Definitive Agreement. |
On February 25, 2020, in connection with a previously announced public offering, Oaktree Specialty Lending Corporation (the Company) and Deutsche Bank Trust Company Americas, as trustee (the Trustee), entered into a Fifth Supplemental Indenture (the Fifth Supplemental Indenture) to the Indenture, dated April 30, 2012, between the Company and the Trustee (the Indenture). The Fifth Supplemental Indenture relates to the Companys issuance, offer and sale of $300 million aggregate principal amount of its 3.500% Notes due 2025 (the Notes).
The Company expects to use the net proceeds of the offering to reduce its outstanding debt and for general corporate purposes. The Company may reborrow under its debt facilities to make investments in accordance with its investment objective and strategies or general corporate purposes.
The Notes mature on February 25, 2025 (the Maturity Date), unless previously redeemed or repurchased in accordance with their terms. The Notes bear interest at a rate of 3.500% per year payable semiannually in arrears on February 25 and August 25 of each year, commencing on August 25, 2020. The Notes are the Companys direct, unsecured obligations and rank senior in right of payment to the Companys future indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to the Companys existing and future unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of the Companys secured indebtedness (including existing unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness; and structurally junior to all future indebtedness (including trade payables) incurred by the Companys subsidiaries, financing vehicles or similar facilities.
At any time or from time to time, the Company may redeem some or all of the Notes at a redemption price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the Notes to be redeemed through January 25, 2025 (the date falling one month prior to the maturity date of the Notes), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus 35 basis points, plus, in each case, accrued and unpaid interest, if any, to, but excluding, the date of redemption; provided, however, that if the Company redeems any Notes on or after January 25, 2025 (the date falling one month prior to the maturity date of the Notes), the redemption price for the Notes will be equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. No sinking fund is provided for the Notes. In addition, if a change of control repurchase event (as defined in the Fifth Supplemental Indenture) occurs in respect of the Company, holders of the Notes may require the Company to repurchase for cash all or part of their Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but not including, the repurchase date.
The Indenture, as supplemented by the Fifth Supplemental Indenture, contains certain covenants, including a covenant requiring the Company to comply with Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act of 1940, as amended, or any successor provisions, but giving effect to any exemptive relief granted to the Company by the Securities and Exchange Commission (the SEC) and to provide financial information to the holders of the Notes and the Trustee if the Company should no longer be subject to the reporting requirements under the Securities Exchange Act of 1934, as amended. These covenants are subject to important limitations and exceptions that are set forth in the Indenture.
The Notes were offered and sold pursuant to the Companys effective shelf registration statement on Form N-2 (Registration No. 333-234798) previously filed with the SEC, as supplemented by a preliminary prospectus supplement dated February 13, 2020, a final prospectus supplement dated February 13, 2020 and the pricing term sheet filed with the SEC on February 13, 2020. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. The transaction closed on February 25, 2020.
The description above is only a summary of the material provisions of the Fifth Supplemental Indenture and the Notes and is qualified in its entirety by reference to copies of the Fifth Supplemental Indenture and the Notes, respectively, each filed as exhibits to this Current Report on Form 8-K and incorporated by reference herein.
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits |
SIGNATURE
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OAKTREE SPECIALTY LENDING CORPORATION | ||||||
Date: February 25, 2020 | By: | /s/ Mel Carlisle | ||||
Name: | Mel Carlisle | |||||
Title: | Chief Financial Officer and Treasurer |